Author

Sabine Grüner

F. Hoffmann-La Roche AG

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Andrea ChiccaiD· 1 shared Antonello CarusoiD· 1 shared Christoph UllmeriD· 1 shared Daniel BátoraiD· 1 shared Jürg GertschiD· 1 shared Jürgen FingerleiD· 1 shared Matthias MülleriD· 1 shared Pál PacheriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Andrea ChiccaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies

Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Härtung, Roland Degen, Matthias Müller, Uwe Grether, Pál Pacher, Jürg Gertsch

This paper develops and characterizes RNB-61, a potent and selective CB2R agonist with favorable pharmacokinetics, showing nephroprotective effects in kidney injury models.

ACS Pharmacology & Translational Science · Jul 9, 2024Peer-reviewedPharmacology & Toxicology